Dr Alicia Groft, MD in Berlin, VT - Psychiatry & Neurology

Dr Alicia Groft, MD is a Psychiatry & Neurology - Psychiatry physician based in Berlin, Vermont. Dr Alicia Groft is licensed to practice in Vermont (license number 042.0011540) and her current practice location is 130 Fisher Rd, In-patient Psych Group, Berlin, Vermont. She can be reached at her office (for appointments etc.) via phone at (802) 371-4316.

NPI number for Dr Alicia Groft is 1598874570 and her current mailing address is Po Box 547, Barre, Vermont. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1598874570.

Contact Information

	Dr Alicia Groft, MD
	130 Fisher Rd, In-patient Psych Group, Berlin, VT 05602-9516
	(802) 371-4316
	(802) 371-4579

Physician's Profile

Full Name	Dr Alicia Groft
Gender	Female
Speciality	Psychiatry & Neurology - Psychiatry
Location	130 Fisher Rd, Berlin, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1598874570
Provider Enumeration Date: 08/30/2006
Last Update Date: 05/01/2013

Medical Identifiers

Medical identifiers for Dr Alicia Groft such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1598874570	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084P0800X	Psychiatry & Neurology - Psychiatry	042.0011540 (Vermont)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Alicia Groft is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Alicia Groft, MD Po Box 547, Barre, VT 05641-0547 Ph: (802) 371-4316	Dr Alicia Groft, MD 130 Fisher Rd, In-patient Psych Group, Berlin, VT 05602-9516 Ph: (802) 371-4316

News Archive

Shire files lawsuit against Watson over ADDERALL XR patent infringement

Shire plc, announces that its subsidiary Shire LLC has filed a lawsuit in the U.S. District Court for the Southern District of New York against Watson Pharmaceuticals, Inc. and its subsidiaries Watson Laboratories, Inc.-Florida, Watson Pharma, Inc., Andrx Corporation, and Andrx Pharmaceuticals, L.L.C. for infringement of Shire's U.S. Reissue Patent No. RE 41,148, U.S. Reissue Patent No. RE 42,096 and U.S. Patent No. 6,913,768 and also for breach of contract.

Heptares announces strategic drug discovery collaboration with Pfizer

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.

Ceremonial groundbreaking for new Children's Hospital of Michigan Specialty Center

Federal, state, and regional legislators and community leaders today join Vanguard Health System's Vice Chairman Keith Pitts, DMC President and CEO Mike Duggan, and Children's Hospital of Michigan President Herman Gray, MD at a ceremonial groundbreaking of the Children's Hospital of Michigan Specialty Center on the campus of the DMC (3950 Beaubien).

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.

Gene linked to inherited blood biomarker associated with asthma risk

Risk for developing asthma is linked to variants in a gene called CHI3L1, which can be measured by checking levels of an inherited blood protein regulated by that gene, according to new research sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

Psychiatry & Neurology Doctors in Berlin, VT

Peter M Thomashow, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd, Central Vermont Medical Center, Berlin, VT 05602 Phone: 802-371-4316 Fax: 802-371-4579
Jessica E O'neil, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 286 Hospital Loop, Berlin, VT 05602 Phone: 802-229-0591 Fax: 802-223-3667
Dr. Ryosuke Kawatsuji, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Central Vermont Medical Center, Berlin, VT 05602 Phone: 802-371-4100
Dr. Justin R. Knapp, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-371-4316 Fax: 802-371-4579
Kenneth Elliot Adler, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-371-4100
Brian Joseph Rosen, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-371-4100
Nicholas Phillips, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-371-4100

Dr Alicia Groft, MD - Psychiatry & Neurology in Berlin, VT